alexa Functional Imaging in Cancer Drug Development: A Mini-Review

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Health and Medical Tourism 2020

Dubai, UAE

2nd European Heart Congress

New York, USA

World Cardiology Summit

New York, USA
Functional Imaging in Cancer Drug Development: A Mini-Review

Cancer drug development is a lengthy process; it can take as long as 15 years for a successful drug to reach to FDA (Food and Drug Administration) approval, going through all the different phases of pre-clinical and clinical research, ie, Phase I/II/III trials. It has been previously estimated that out of 10,000 chemical compounds initially tested in pre-clinical studies, only 5 are eventually assessed in clinical trials, and only one achieves to gain official approval. Furthermore, the final cost of the whole process until a drug reaches FDA approval has been approximately estimated to exceed $ 800,000,000.

Citation: Papanastasopoulos P (2014) Functional Imaging in Cancer Drug Development: A Mini-Review. J Med Diagn Meth 3:157. doi: 10.4172/2168-9784.1000157

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger